Cinacalcet
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01012 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 14 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 2 | common cold | KG + DL |
| 3 | female breast carcinoma | KG + DL |
| 4 | multiple endocrine neoplasia | KG + DL |
| 5 | headache disorder | KG + DL |
| 6 | trigeminal autonomic cephalalgia | KG + DL |
| 7 | hypertrichosis (disease) | KG + DL |
| 8 | subarachnoid hemorrhage (disease) | KG + DL |
| 9 | pulmonary hypertension | KG + DL |
| 10 | obsolete familial combined hyperlipidemia | KG + DL |
| 11 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 12 | kyphoscoliotic heart disease | KG + DL |
| 13 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 14 | Ambras type hypertrichosis universalis congenita | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.